Hosted on MSN13d
Minoryx Announces Dosing of the First Patient with Leriglitazone in the Phase 2a Study in Rett Syndrome (TREE Study)
Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system ...
Neurogene: Potential To Target Root Cause Of Rett Syndrome With NGN-401
NGNE to update on a potential registrational phase 3 study, using NGN-401, for the treatment of patients with Rett Syndrome.
PharmaTimes8d
Minoryx doses first patient with leriglitazone in Rett syndrome study
Phase 2a TREE study assesses safety and efficacy of leriglitazone Minoryx Therapeutics has dosed the first patient in its phase 2a TREE study, which evaluates the safety and efficacy of leriglitazone ...
SBS2y
Run For the Kids: Pinoy family runs to raise awareness about Rett syndrome
Melbourne couple, with their daughter Thadine, who has Rett syndrome, will take part in Sunday ... Since then, it has become a tradition for their family and friends to run for Thadine’s ...
Baylor College of Medicine1y
Blue Bird Circle Rett Center
The Rett Center at Baylor is one of the few centers in the United States that specializes in the diagnosis and care of children and adults with Rett Syndrome ... up with a written acknowledgment to ...
manilatimes7d
Rett Syndrome Research Trust Appoints Amy Gilliland to its Board of Trustees
March 13, 2025 (GLOBE NEWSWIRE) -- The Rett Syndrome Research Trust (RSRT), the organization ... I know for Amy advancing Rett research is a family affair. Her husband, John, and son, Patrick, and ...